Bicara Therapeutics Inc. Common Stock (BCAX) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$0.21 (-2.12%)

Last update: 04:00 PM EST

Day's range

$9.47

$9.85

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date	Details
05/23/2025	Wells Fargo	Eva Fortea Verdejo	$8.00	$9.27	-13.7%
10/08/2024	Morgan Stanley	Judah Frommer	$35.00	$24.45	43.15%

Bicara Therapeutics Inc. Common Stock FAQ's

Bicara Therapeutics Inc. Common Stock has been rated by research analysts at Wells Fargo, Stifel Nicolaus, Morgan Stanley in the past 90 days.

New Alert

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.

Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.

In future if you don't want to receive any email then delete stocks added into alert section.

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.